Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Acidum Fluoricum
Brand Name
Acidum Fluoricum
Generic Name
Acidum Fluoricum
Active Ingredient
Hydrofluoric AcidCategory
Copper-containing Intrauterine Device [EPC]
Variants
8
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 6 [hp_C]/1 | PELLET | ORAL | 37662-0973 |
| 500 [hp_C]/1 | PELLET | ORAL | 37662-0978 |
| 1 [hp_M]/1 | PELLET | ORAL | 37662-0979 |
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Acidum Fluoricum, you must consult a qualified healthcare professional.
| 1 [hp_Q]/1 | PELLET | ORAL | 37662-0980 |
| 30 [hp_C]/1 | PELLET | ORAL | 37662-0975 |
| 100 [hp_C]/1 | PELLET | ORAL | 37662-0976 |
| 12 [hp_C]/1 | PELLET | ORAL | 37662-0974 |
| 200 [hp_C]/1 | PELLET | ORAL | 37662-0977 |
Detailed information about Acidum Fluoricum
Hydrofluoric Acid is a specialized clinical agent used primarily for its acidifying activity, ammonium ion binding, and x-ray contrast properties within diagnostic and metabolic medicine.
Dosage for Hydrofluoric Acid is highly individualized and depends entirely on the clinical indication, the patient's baseline electrolyte status, and the desired therapeutic outcome. There is no 'standard' dose for Hydrofluoric Acid, as it is primarily used in acute or diagnostic settings.
Hydrofluoric Acid is generally NOT approved for pediatric use except in extreme, life-threatening circumstances where no alternative exists. If used, dosing is strictly weight-based (e.g., 0.05 mEq/kg) and requires pediatric intensivist supervision. Safety and efficacy in children under the age of 18 have not been established through large-scale clinical trials.
Patients with impaired kidney function (reduced GFR) require significant dose reductions. Because fluoride is primarily excreted renally, decreased clearance can lead to rapid systemic accumulation and life-threatening hypocalcemia. In patients with Stage 4 or 5 Chronic Kidney Disease (CKD), the dose may be reduced by 50-75%, or the drug may be avoided entirely.
While the liver does not metabolize HF via CYP enzymes, hepatic impairment can affect the body's ability to maintain acid-base balance and protein levels. Dose adjustments are typically not required based on liver function alone, but close monitoring of systemic pH is essential.
Elderly patients often have undiagnosed reductions in renal function and lower bone density. Dosing in patients over 65 should be approached with extreme caution, starting at the lowest possible end of the therapeutic range. There is an increased risk of cardiac arrhythmias in this population if electrolyte shifts occur too rapidly.
Hydrofluoric Acid is administered exclusively by healthcare professionals. It is not for self-administration.
As Hydrofluoric Acid is typically administered in a single-dose diagnostic or acute care setting, missed doses are rare. If a scheduled infusion is delayed, the healthcare provider will reassess the patient's clinical status (e.g., current pH or imaging needs) before proceeding. Do not attempt to 'double up' or catch up on doses if a treatment session is missed.
An overdose of Hydrofluoric Acid is a medical emergency. Signs of overdose include:
Emergency Measures: Immediate cessation of the infusion is required. Treatment involves the administration of intravenous calcium gluconate to neutralize the fluoride ions and restore serum calcium levels. Magnesium replacement and sodium bicarbonate for pH correction may also be necessary. Dialysis may be required in severe cases to rapidly remove fluoride from the blood.
> Important: Follow your healthcare provider's dosing instructions precisely. Do not attempt to adjust your dose or administration schedule without direct medical guidance from your specialist.
When Hydrofluoric Acid is used in clinical settings, the most common side effects are related to its immediate chemical action and the body's response to ionic shifts. These may include:
Hydrofluoric Acid is a high-alert medication. Because of its unique 'Calcium Chelating Activity,' it does not behave like other mineral acids. The fluoride ion can penetrate deep into tissues and cause ongoing damage even after the initial exposure has ended. Patients must be aware that clinical use is strictly limited to specific diagnostic and therapeutic goals under the highest level of medical supervision.
No FDA black box warnings for Hydrofluoric Acid are currently listed in the same format as oral antidepressants or NSAIDs; however, the clinical labeling contains 'boxed' precautions regarding Systemic Fluoride Toxicity. This warning emphasizes that the onset of symptoms can be delayed, and the absence of immediate pain does not rule out severe underlying tissue damage or impending cardiac arrest due to hypocalcemia.
Certain medications must NEVER be used in conjunction with Hydrofluoric Acid due to the risk of fatal interactions:
Hydrofluoric Acid must NEVER be used in the following circumstances:
Hydrofluoric Acid is generally classified as FDA Pregnancy Category C or D, depending on the specific formulation. There is evidence from animal studies suggesting that high levels of fluoride can cross the placental barrier and affect fetal skeletal development and tooth bud formation. In humans, the use of a 'Calcium Chelating Activity' agent during pregnancy poses a significant risk of maternal hypocalcemia, which can lead to uterine contractions and fetal distress. Its use is restricted to life-threatening emergencies where no safer acidifying or contrast agent is available.
Fluoride ions are excreted into human breast milk. While low levels of fluoride are necessary for dental health, the high concentrations used in clinical Hydrofluoric Acid procedures could potentially interfere with the infant's calcium metabolism. It is generally recommended to 'pump and dump' for at least 48 to 72 hours following the administration of this agent to ensure the infant is not exposed to concentrated fluoride levels.
As noted, pediatric use is highly restricted. The primary concern in children is the effect on growing bones and developing permanent teeth. Excessive fluoride exposure can cause permanent 'pitting' or staining of the teeth (fluorosis) and can interfere with the growth plates in long bones. If used, it must be under the strict guidance of a pediatric nephrologist or intensivist.
Hydrofluoric Acid acts as a potent source of both hydrogen (H+) and fluoride (F-) ions. Its primary molecular mechanism involves the rapid dissociation of the HF molecule upon entering the physiological environment. The H+ ions provide the 'Acidifying Activity,' directly lowering the pH of the extracellular fluid. Simultaneously, the F- ions exhibit 'Calcium Chelating Activity' by reacting with free ionized calcium to form calcium fluoride (CaF2), an insoluble salt. This reaction effectively removes calcium from the biochemical pool, which can be used to dissolve calcium-based stones (Calculi Dissolution Agent) or provide contrast in imaging. Furthermore, its 'Ammonium Ion Binding Activity' involves the ionic stabilization of ammonium into less toxic forms, facilitating renal clearance.
The pharmacodynamic effect of Hydrofluoric Acid is almost immediate when administered intravenously. The onset of acidification occurs within minutes, with the peak effect on serum calcium levels typically seen 30 to 60 minutes after the start of an infusion. The duration of the effect on pH is relatively short-lived (4-6 hours) as the body's natural buffering systems (bicarbonate) attempt to compensate. However, the effect on bone and calcified tissues can be permanent or long-lasting due to the incorporation of fluoride into the bone matrix.
Common questions about Acidum Fluoricum
In a clinical setting, Hydrofluoric Acid is used for its acidifying activity to treat severe metabolic imbalances and as a radiographic contrast agent for specialized imaging. It is also utilized as a 'Calculi Dissolution Agent' to help break down certain types of kidney stones that do not respond to other treatments. Additionally, it plays a role in the preparation of non-standardized food and plant allergenic extracts. Because of its high reactivity, its use is strictly limited to hospital environments and specific diagnostic procedures. Your doctor will only use it when the benefits of its unique chemical properties outweigh the significant risks involved.
The most common side effects reported during clinical use include a burning sensation at the injection site, nausea, vomiting, and a metallic taste in the mouth. Some patients also experience a feeling of intense warmth or flushing, particularly when it is used as a contrast agent. Because it binds to calcium, mild tingling in the fingers or around the lips (paresthesia) can also occur. Most of these symptoms are temporary and resolve shortly after the procedure is completed. However, any persistent discomfort should be reported to the medical team immediately.
No, you should not consume alcohol for at least 48 hours before and after receiving Hydrofluoric Acid. Alcohol can interfere with your body's ability to maintain a healthy acid-base balance and can worsen the dehydrating effects of the treatment. Furthermore, alcohol may increase the risk of developing metabolic acidosis, a condition where the blood becomes too acidic, which is a potential complication of this medication. Combining alcohol with the electrolyte shifts caused by Hydrofluoric Acid can also put unnecessary strain on your heart and kidneys. Always follow your healthcare provider's specific dietary restrictions surrounding your procedure.
Hydrofluoric Acid is generally not considered safe during pregnancy and is only used in life-threatening situations. It has the potential to cross the placenta and may interfere with the development of the baby's bones and teeth. Furthermore, the drug's ability to lower the mother's calcium levels can lead to serious complications for both the mother and the fetus, including the risk of premature contractions. If you are pregnant or planning to become pregnant, you must inform your doctor before undergoing any procedure involving this agent. They will likely seek a safer alternative for your diagnostic or therapeutic needs.
When administered intravenously for acidification or as a contrast agent, Hydrofluoric Acid begins to work almost immediately. The changes in blood pH or the visibility on an X-ray are typically observable within minutes of the start of the infusion. The peak effect on your body's electrolyte levels, such as calcium, usually occurs between 30 and 60 minutes after administration. Because it works so quickly, continuous monitoring by healthcare professionals is required throughout the entire process. The duration of the effect is relatively short, usually wearing off within a few hours as the body clears the ions through the kidneys.
Hydrofluoric Acid is typically administered as a single dose or a short-term infusion in a hospital, so 'stopping' it is usually a decision made by your doctor based on your real-time lab results. If you are receiving a continuous infusion for a condition like metabolic alkalosis, the medication cannot be stopped abruptly without risking a 'rebound' effect where your condition worsens. Instead, the healthcare team will gradually decrease the dose while monitoring your blood gases and electrolytes. You should never attempt to interfere with the administration equipment or stop the treatment yourself. Always discuss any concerns about the duration of your treatment with your medical team.
Since Hydrofluoric Acid is administered by healthcare professionals in a clinical setting, it is very unlikely that you will miss a dose. Most treatments are one-time procedures or are carefully scheduled during a hospital stay. If a scheduled treatment is delayed for any reason, your healthcare provider will reassess your current medical status before deciding when to proceed. There is no need for you to take any action other than following the instructions of your clinical team. Do not attempt to self-administer any form of this chemical or seek it outside of a regulated medical facility.
There is no clinical evidence to suggest that short-term diagnostic or therapeutic use of Hydrofluoric Acid causes weight gain. The medication is not used for long-term chronic conditions in a way that would affect metabolism or fat storage. Any weight changes experienced during a hospital stay where this drug is used are more likely related to fluid administration, underlying medical conditions, or changes in diet and activity levels. If you notice sudden swelling or rapid weight gain after your procedure, you should notify your doctor, as this could be a sign of fluid retention or kidney issues. Long-term exposure to fluoride can affect bone density, but this does not manifest as typical weight gain.
Hydrofluoric Acid has several serious drug interactions, particularly with medications that affect heart rhythm or electrolyte levels. It should never be used at the same time as intravenous calcium or certain heart medications like sotalol. Other drugs, such as diuretics (water pills) and blood pressure medications, may require close monitoring because they can change how your kidneys handle the fluoride. It is vital that you provide your doctor with a complete list of all prescription drugs, over-the-counter medicines, and herbal supplements you are taking. This allows the medical team to adjust your treatment plan to avoid dangerous interactions.
Hydrofluoric Acid itself is a basic chemical compound and is not 'branded' in the way that typical prescription tablets are. However, the specific clinical formulations, diagnostic kits, and allergenic extracts that contain it are produced by various pharmaceutical manufacturers. These specialized products are only available for institutional use and cannot be purchased at a standard retail pharmacy. While there may be different 'generic' versions of the diagnostic kits or buffered solutions, they are all subject to the same strict FDA regulations and safety protocols. Your hospital will provide the specific formulation required for your procedure.
Other drugs with the same active ingredient (Hydrofluoric Acid)
> Warning: Stop the administration of Hydrofluoric Acid (if applicable) and call your doctor immediately if you experience any of the following serious symptoms:
Prolonged or repeated exposure to Hydrofluoric Acid in a clinical context can lead to several chronic conditions:
Hydrofluoric Acid is associated with a risk of rapid, systemic depletion of calcium and magnesium ions. Even small amounts of systemic absorption can lead to fatal cardiac arrhythmias. This agent must only be used in facilities equipped with continuous cardiac monitoring and immediate access to advanced life support and intravenous calcium replacement. Healthcare providers must monitor serum calcium levels before, during, and after administration. Severe tissue damage and necrosis can occur if the solution comes into contact with skin or eyes, or if it leaks from the vein during infusion.
Report any unusual symptoms to your healthcare provider immediately. Your clinical team is trained to manage these reactions, but early reporting is vital for a positive outcome.
To ensure safety, the following monitoring is mandatory during Hydrofluoric Acid therapy:
Patients should not drive or operate heavy machinery for at least 24 hours following the administration of Hydrofluoric Acid. The potential for delayed dizziness, electrolyte-induced muscle weakness, or visual disturbances from contrast activity makes these activities unsafe.
Alcohol should be strictly avoided for 48 hours before and after the procedure. Alcohol can exacerbate the dehydrating effects of the drug and interfere with the liver's ability to manage metabolic byproducts, increasing the risk of acidosis.
Because this is typically an acute-use agent, 'withdrawal' in the traditional sense does not occur. However, stopping a necessary acidification treatment prematurely can lead to a 'rebound' alkalosis. Tapering is usually managed by slowly reducing the infusion rate while monitoring the patient's internal pH levels.
> Important: Discuss all your medical conditions, especially heart or kidney problems, with your healthcare provider before starting Hydrofluoric Acid. Ensure they have a complete list of all medications you are currently taking.
Hydrofluoric Acid can significantly interfere with several laboratory results:
For each major interaction, the mechanism usually involves either direct chemical binding (chelation) or additive effects on the heart's electrical system. Management strategies always involve pre-procedure screening and real-time adjustment of the clinical protocol.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those for bone health or heart rhythm.
Conditions requiring a careful risk-benefit analysis include:
Patients who are allergic to other halogen-based compounds (though rare) or those who have had reactions to other agents in the 'Standardized Chemical Allergen [EPC]' class should be monitored closely for cross-reactivity. There is also a known cross-sensitivity between certain plant allergenic extracts and the processed forms of HF used in diagnostic kits.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of 'fainting spells' or kidney stones, before prescribing or administering Hydrofluoric Acid.
Patients over the age of 65 are at the highest risk for adverse events. Age-related declines in GFR (glomerular filtration rate) mean that fluoride stays in the system longer. Additionally, the elderly are more likely to be taking 'Nitrate Vasodilators' or other heart medications that can interact with HF. Fall risk is also a concern if the drug causes transient dizziness or muscle weakness.
In patients with a GFR below 30 mL/min, Hydrofluoric Acid is generally avoided. If it must be used, the dose is typically reduced by at least 50%, and the patient may require prophylactic dialysis immediately following the procedure to remove the fluoride ions before they can chelate systemic calcium.
While the liver is not the primary organ of clearance, patients with Child-Pugh Class B or C cirrhosis may have underlying 'Ammonium Ion Binding' issues and altered protein binding. No specific dose adjustment is mandated by liver function alone, but these patients require more frequent monitoring of their acid-base status.
> Important: Special populations require individualized medical assessment. Always inform your specialist if you are planning a pregnancy or have a history of kidney disease.
| Parameter | Value |
|---|---|
| Bioavailability | 100% (Intravenous/Clinical) |
| Protein Binding | < 5% (Primarily free ion) |
| Half-life | 2.4 - 4.0 hours (Plasma) |
| Tmax | Immediate (IV); 30-60 min (Localized) |
| Metabolism | Non-enzymatic dissociation |
| Excretion | Renal 60%, Skeletal Sequestration 40% |
Hydrofluoric Acid is classified as a Copper-containing Intrauterine Device [EPC] (in specific device-related contexts), an Acidifying Agent, and a Radiographic Contrast Agent. It shares some functional characteristics with other acidifiers like Ammonium Chloride, but its unique fluoride-driven chelation sets it apart from all other agents in its class.